Skye Bioscience SKYE
NASDAQ SKYE
$1.68 +0.08 (+5.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Sales of Property, Plant and Equipment (2023 - 2026)

Updated

Skye Bioscience's Sales of Property, Plant and Equipment came in at $850.00 for Q1 2026.

Analysis

Skye Bioscience (SKYE) Sales of Property, Plant and Equipment (2023 - 2026) Analysis & Trends

For FY2013, Skye Bioscience's Sales of Property, Plant and Equipment was $11,000.

  • The Q1 2026 figure represents the highest quarterly Sales of Property, Plant and Equipment since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Skye Bioscience 7.38 Mn 7.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 850.00
Sep 30, 2024 72,837.00
Mar 31, 2024 1.15 Mn
Mar 31, 2023 5.53 Mn
API Access

Skye Bioscience Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=SKYE&period=max&api_key=YOUR_API_KEY